Gossamer Bio, Inc. (GOSS)
0.4216
+0.02
(+5.24%)
USD |
NASDAQ |
Apr 14, 12:01
Gossamer Bio Cash from Investing (TTM) : 156.36M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 94.86M |
| Artelo Biosciences, Inc. | -0.0639M |
| Arvinas, Inc. | 407.60M |
| Quince Therapeutics, Inc. | 23.23M |
| Vir Biotechnology, Inc. | 310.37M |